MedTrace Logo

Prevention and Treatment of AKI VEXUS Guided Post Cardiac Surgery

NCT06972082 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 304

Last updated 2025-05-14

No results posted yet for this study

Summary

The main goal of this clinical trial is to learn if evaluation by ultrasound of venous congestion of liver and kidneys can guide treatment and prevent and treat acute kidney injury post cardiac surgery (CSA-AKI).

Participants will:

Be evaluated by liver and kidney veins ultrasound (treatment group) or a placebo post CSA-AKI.

Fluid management for the treatment group will be based on a score that emerges from this evaluation (Venous Excess Ultrasound Score, VEXUS).

Kidney function will be daily monitored and followed-up for 7 days and until discharge.

Daily fluid balance and laboratory examination will be performed. Data will be recorded and collected and a statistical analysis will provide the results that will show or not a probable superiority of this evaluation comparing to the usual care.

Conditions

Interventions

DEVICE

VEXUS

Goal-directed fluid and drug therapy according to VEXUS measurements to minimize AKI

Sponsors & Collaborators

  • Onassis Cardiac Surgery Centre

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-29
Primary Completion
2025-06-30
Completion
2025-10-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06972082 on ClinicalTrials.gov